Latest Abbot Laboratories Stories

2009-09-28 15:37:32

U.S. pharmaceutical giant Abbot Laboratories said it would buy Belgian drug company Solvay's prescription drug division for $6.6 billion cash. In doing so, Abbott would take full possession of TriCor, an anti-cholesterol pill that took in $1.3 billion in sales in 2008, The New York Times reported Monday. Currently, Abbot and Solvay share in TriCor's proceeds. In addition, Abbott will fully own Trilipix, a new cholesterol treatment the Food and Drug Administration approved in December. Solvay...

Word of the Day
  • Scandinavian punch made of claret and aquavit with spices and raisins and orange peel and sugar.
This word comes from the Swedish 'glogg,' which is an alteration of 'glodgat,' mulled (wine).